Audit Diagnostics

995 Words4 Pages

Product Profile As described in a study by Lukasz and Piotr (2012), it is extremely important that certain companies (depending on the market) develop a wide product range. Following their example, Audit Diagnostics manufactured a very broad range of products. Each of these products had unique characteristics and features. They range from products such as automated preparation stations, clinical analysers and rapid diagnostic/veterinary tests, to ELISA biochemical techniques, liquid stable reagents and sanitisers/infection control apparatuses. Cellslide is an automated computer controlled thin layer cytology preparation station (LBC) providing premium cytological slides for the examination of PAP Tests, Urine Tests and Thyroid Tests (Audit …show more content…

Audit Diagnostics’ reagents offer increased accuracy and reliability. Audit Diagnostics’ new ‘hygiene revolution’ known as the Sterl STAT range provides the total solution for sanitisation and infection control (Anderco 2011). The mode of action is both physical and chemical. The physical effect is creating by varying surface tension. Sterl STAT contains a polydimethylsiloxane based polymer which has a low surface tension and is hydrophobic. However, it also contains many further components of a relatively higher surface tension. Such a surface makes it difficult for micro-organisms to settle and produce a biofilm. Micro-organisms are susceptible to the gentle biocides associated with the polymer backbone of Sterl STAT making it an ideal solution to fighting …show more content…

This development had gone against the norm of what Audit Diagnostics would normally produce. They were further enhancing this range with the introduction of a complete range of Rapid Tests for the rapid diagnosis of the most common diagnostic requirements for animals. The most recent R&D development in Audit Diagnostics is the Sterl Stat range of products. Audit Diagnostics noticed a gap in the market for a ‘hygiene revolution’ and positioned themselves accordingly, launching the Sterl STAT range which provides the total solution for sanitisation and infection control. This hugely successful launch is another perfect example of how creating new R&D partnerships can help Audit Diagnostics to develop successful products. However, successful products do not automatically guarantee commercial success. The fluctuating world of business also depends on many other variables and Audit Diagnostics has fallen victim to liquidation. Its R&D department has taken a significant hit, putting future development projects in serious jeopardy. If circumstances improve and its R&D department is reinstated, I believe that Audit Diagnostics will re-establish their previous practice of creating and maintaining R&D partnerships with different

Open Document